Pharma Use of Rx Data Survey

1. Introduction

 
Thanks for taking a few minutes to respond to the following survey and giving us your thoughts.

After finishing the survey, you will be taken to a summary review of the results to date. No open-ended results that may contain personal information of respondents will be shown.

Your response is confidential - we do not reveal your answers in association with personally-identifiable information unless you give us permission to do so. Aggregate results will be reported in a future issue of Pharma Marketing News and will be available on the Pharma Marketing Network website Survey Page.

If you have any problems with this survey or questions, please contact John Mack at 215-504-4164 or johnmack@virsci.com.

*
1. Please indicate your affiliation (choose the one that best describes the type of organization you are involved in).
THE ISSUE: Limiting Pharma Access to Physician Prescribing Data

Pharmaceutical companies use physician prescribing data for a variety of purposes, but arguably mostly for sales and marketing purposes.

Some doctors object to the use of prescribing data to target them for marketing. New Hamspire has recently passed a bill limiting the sales of physician Rx data to pharmaceutical companies for "commercial purposes," including -- but not limited to -- marketing purposes.

This issue is discussed in more detail on Pharma Marketing Blog: Who's Data Is It Anyway? and Specious Arguments in Favor of Rx Data Use.

*
2. Please indicate whether you agree or disagree with each of the following statements regarding the benefits of pharma use of physician prescribing data:
Agree stronglyAgree somewhatNeither agree nor disagreeDisagree somewhatDisagree strongly
Prescribing data allow pharmaceutical promotion to be relevant and specific, making the whole process more cost-effective
Physician prescribing data helps manufacturers to alert physicians of important new information about medicines in a timely fashion
*
3. Please indicate whether you agree or disagree with each of the following statements regarding physicians right to opt-out of having their Rx data sold to pharma companies:
Agree stronglyAgree somewhatNeither agree nor disagreeDisagree somewhatDisagree strongly
Physicians should be able to opt-out of having their Rx data sold to pharma companies for ANY USE
Physicians should be able to opt-out of having their Rx data sold to pharma companies for MARKETING PURPOSES ONLY
Physicians should NOT be able to opt-out of having their Rx data sold to pharma companies
*
4. Which of the following possible uses of physician Rx data by pharma companies do you think is appropriate? (Check all that apply.)
5. Because there are many nuances that may have influenced your answers, your comments here will help explain your choices in the previous questions.
6. Pharma Marketing Network maintains a list of experts in pharmaceutical marketing, advertising, and sales. We contact experts to interview for articles, recruit speakers for our educational audio conferences, for referrals to reporters or executive recruiters, etc.

If you wish to be contacted or listed as an expert on this subject, please provide your contact information below.
7. Please provide additional details regarding your areas of expertise here.
Powered by SurveyMonkey
Check out our sample surveys and create your own now!